Breaking News Instant updates and real-time market news.

FB

Facebook

$188.88

0.07 (0.04%)

, AVGO

Broadcom

$288.01

-2.45 (-0.84%)

13:17
10/16/19
10/16
13:17
10/16/19
13:17

European Commission exploring investigation of Facebook, NY Times reports

The European Commission is exploring an investigation of Facebook (FB), The New York Times' Adam Satariano reports, citing a person familiar with the matter. The report comes as the Commission ordered Broadcom (AVGO) to stop applying certain provisions contained in agreements with six of its main customers. Reference Link

FB

Facebook

$188.88

0.07 (0.04%)

AVGO

Broadcom

$288.01

-2.45 (-0.84%)

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

FB Facebook
$188.88

0.07 (0.04%)

10/10/19
10/10/19
UPGRADE
Target $89

Outperform
Match Group upgraded to Outperform at Oppenheimer
As previously reported, Oppenheimer analyst Jason Helfstein upgraded Match Group (MTCH) to Outperform from Perform, with a price target of $89. The analyst notes that the stock is down 27% from its highs on an overall correction in momentum names, confusion surrounding a likely debt transfer as part ofthe spinoff from IAC (IAC) and concerns over the FTC lawsuit. Helfstein is now less concerned about competition from Facebook (FB) Dating, and highlights that 3P download data shows an acceleration in Tinder and localized offerings. Lastly, his survey work indicates that only 44% of U.S. singles are currently using an online dating product, suggesting material growth in overall usage.
10/15/19
RSBL
10/15/19
NO CHANGE
Target $242
RSBL
Buy
Rosenblatt a buyer of Facebook shares into Q3 report
Rosenblatt analyst Mark Zgutowicz is a buyer of Facebook shares into the company's Q3 results on Wednesday, October 30. Demand side indications remain strong for both News Feed and Instagram as respective return on ad spend remains at the top end of advertiser buys, Zgutowicz tells investors in a research note. However, with Facebook "under a regulator microscope," the analyst does not expect a "big" beat and raise quarter, but rather a modest beat and reduction to 2019 expense growth guidance. With the stock trading at 19 times estimated 2020 earnings, a modest beat will satisfy "the bar," contends Zgutowicz. He reiterates a Buy rating on Facebook with a $242 price target.
10/15/19
JEFF
10/15/19
NO CHANGE
JEFF
Jefferies selective on Internet into Q3, most positive on Alphabet and Facebook
Jefferies analyst Brent Thill, who is "generally positive" on Internet sector fundamentals, tells investors to remain selective ahead of Q3 earnings. The analyst is most bullish on Alphabet (GOOGL), Facebook (FB), Expedia (EXPE), and Wix.com (WIX). He remains underweight TripAdvisor (TRIP), Shutterstock (SSTK), and Endurance (EIGI). Thill is most positive on Alphabet and Facebook. Alphabet's setup is better in the second half of the year relative to the first half due to easier comps, healthy core advertising, momentum in Google Cloud, and expanded hardware line-up ahead of the holidays, the analyst tells investors in a research note. He also likes Facebook's setup due to easier second half comps, recent product innovation on Instagram Commerce, and improvements to the core Facebook app. In e-commerce, Thill is a buyer of Amazon.com (AMZN) on any pullback. In travel, he like Expedia (EXPE) over Booking Holdings (BKNG). The analyst also views the recent selloff in Match Group (MTCH) shares as a buying opportunity.
10/16/19
BARD
10/16/19
NO CHANGE
Target $230
BARD
Outperform
Facebook checks generally positive but guidance could be overhang, says Baird
Baird analyst Colin Sebastian said Facebook will likely see upside to his and the Street's Q3 estimates as agency and advertiser checks suggest relatively steady growth rates versus the slowdown implied by guidance. The analyst believes the company's focus on privacy, data security, messaging , and other product improvements will continue to weigh on margins but he thinks it is likely embedded in investor expectations and consensus estimates. Sebastian reiterated his Outperform rating and $230 price target on Facebook shares.
AVGO Broadcom
$288.01

-2.45 (-0.84%)

09/16/19
ARGS
09/16/19
NO CHANGE
Target $350
ARGS
Buy
Broadcom attractively valued at 'significant discount', says Argus
Argus analyst Jim Kelleher kept his Buy rating and $350 price target on Broadcom after its Q3 results, saying that while the quarter topped expectations, the company guided cautiously for Q4 and the stock dipped. The analyst believes however that Broadcom's strong cash flow outlook remains intact, and it is now "attractively valued" at a "significant discount" relative to its recent valuations. Kelleher states that investors may have hoped for higher guidance given the improving enterprise demand, but contends that the reaffirmed FY19 outlook suggests the management expects the upcoming smartphone season to be "okay".
10/01/19
KEYB
10/01/19
NO CHANGE
KEYB
iPhone 11 Pro/Max demand in line, iPhone 11 sell-through disappoints, says KeyBanc
KeyBanc analyst John Vinh says his initial round of carrier surveys for the Apple (AAPL) iPhone 11/Pro cycle indicates soft demand for the new lineup, especially the iPhone 11. While Apple's initial ramp was split evenly between 11 and Pro, the Pro/Max series demand is apparently better than iPhone 11 despite the price cut, he adds. Overall, the analyst notes that sell-through is tracking close to last year's iPhone XS/XR cycle, while somewhat worse than store expectations. Meanwhile, inventory appears to be lean for iPhone 11 Pro/Max as most stores ran out of stock soon after launch, whereas iPhone 11 inventory stood at one-plus days, he contends. Vinh's favorite Apple supply chain name is Broadcom (AVGO).
10/02/19
OTRG
10/02/19
NO CHANGE
OTRG
Broadcom largest RF dollar content vendor for new iPhones, says OTR Global
OTR Global said its review of available teardowns for Apple's (AAPL) new iPhones confirms that Broadcom (AVGO) was "again" the largest RF dollar content vendor and has gained share in device SKUs from Qorvo (QRVO).
10/10/19
LBOW
10/10/19
UPGRADE
Target $260
LBOW
Buy
Longbow upgrades Apple to Buy on better than forecast demand for new iPhones
As previously reported, Longbow analyst Shawn Harrison upgraded Apple to Buy from Neutral with a $260 price target. His contacts, who previously gave him initial conservative forecasts for up to a 10% year-over-year decline in iPhone production in the calendar third quarter, now see flat production in the period of Apple's fiscal fourth quarter, Harrison tells investors. He estimate the iPhone 11 comprises approximately 50% of new model production and his contacts now see fiscal Q1 year-over-year growth in iPhone shipments of potentially 10% or more, Harrison stated. He also calls out Apple suppliers Skyworks (SWKS), Qorvo (QRVO) and Broadcom (AVGO) as those he covers that are best positioned to see upside based on better than expected iPhone production.

TODAY'S FREE FLY STORIES

07:49
11/15/19
11/15
07:49
11/15/19
07:49
Conference/Events
JMP Securities to hold a bus tour »

Medical Devices &…

DHR

Danaher

$136.16

-0.89 (-0.65%)

07:47
11/15/19
11/15
07:47
11/15/19
07:47
Conference/Events
Danaher management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

CGC

Canopy Growth

$15.84

-2.68 (-14.47%)

07:46
11/15/19
11/15
07:46
11/15/19
07:46
Downgrade
Canopy Growth rating change  »

Canopy Growth downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

EBIX

Ebix

$32.80

-3.6 (-9.89%)

07:46
11/15/19
11/15
07:46
11/15/19
07:46
Hot Stocks
Ebix says offer accepted by Committee of Creditors for Trimax IT assets »

Ebix announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CY

Cypress Semiconductor

$23.43

0.01 (0.04%)

07:45
11/15/19
11/15
07:45
11/15/19
07:45
Downgrade
Cypress Semiconductor rating change  »

Cypress Semiconductor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$120.65

-0.41 (-0.34%)

07:44
11/15/19
11/15
07:44
11/15/19
07:44
Recommendations
Walmart analyst commentary  »

Walmart price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHNG

Change Healthcare

$13.91

0.74 (5.62%)

07:43
11/15/19
11/15
07:43
11/15/19
07:43
Conference/Events
Change Healthcare management to meet with SunTrust »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

BGNE

BeiGene

$195.90

-1.25 (-0.63%)

, AZN

AstraZeneca

$47.37

-0.47 (-0.98%)

07:43
11/15/19
11/15
07:43
11/15/19
07:43
Recommendations
BeiGene, AstraZeneca, AbbVie analyst commentary  »

BeiGene price target…

BGNE

BeiGene

$195.90

-1.25 (-0.63%)

AZN

AstraZeneca

$47.37

-0.47 (-0.98%)

ABBV

AbbVie

$87.61

0.94 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 07

    Dec

  • 27

    Feb

LPTX

Leap Therapeutics

$0.57

-0.5922 (-50.83%)

07:43
11/15/19
11/15
07:43
11/15/19
07:43
Downgrade
Leap Therapeutics rating change  »

Raymond James cuts Leap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$209.88

1.33 (0.64%)

07:42
11/15/19
11/15
07:42
11/15/19
07:42
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 06

    Jan

DFS

Discover

$84.76

0.42 (0.50%)

07:41
11/15/19
11/15
07:41
11/15/19
07:41
Hot Stocks
Discover reports October net charge-off rate 3.27% vs. 3.32% last month »

Reports October 30-plus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBWTF

Auxly Cannabis

$0.00

(0.00%)

07:41
11/15/19
11/15
07:41
11/15/19
07:41
Hot Stocks
Auxly Cannabis announces launch of Robinsons Outdoor Grow cultivation project »

Auxly Cannabis Group,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGC

Canopy Growth

$15.84

-2.68 (-14.47%)

, ACB

Aurora Cannabis

$3.29

-0.25 (-7.06%)

07:40
11/15/19
11/15
07:40
11/15/19
07:40
Recommendations
Canopy Growth, Aurora Cannabis analyst commentary  »

Canopy Growth, Aurora…

CGC

Canopy Growth

$15.84

-2.68 (-14.47%)

ACB

Aurora Cannabis

$3.29

-0.25 (-7.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

07:40
11/15/19
11/15
07:40
11/15/19
07:40
General news
Treasury Market Outlook: yields are a little cheaper »

Treasury Market Outlook:…

NVDA

Nvidia

$209.88

1.33 (0.64%)

07:39
11/15/19
11/15
07:39
11/15/19
07:39
Recommendations
Nvidia analyst commentary  »

Nvidia data center…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 06

    Jan

GDS

GDS Holdings

$44.55

1.61 (3.75%)

07:39
11/15/19
11/15
07:39
11/15/19
07:39
Recommendations
GDS Holdings analyst commentary  »

GDS Holdings price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

ARWR

Arrowhead

$48.51

-0.06 (-0.12%)

07:39
11/15/19
11/15
07:39
11/15/19
07:39
Hot Stocks
Arrowhead announces COO Bruce Given to retire, names new CMO and CSO »

Arrowhead announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

CEMI

Chembio Diagnostics

$4.31

0.3 (7.48%)

07:38
11/15/19
11/15
07:38
11/15/19
07:38
Conference/Events
Chembio Diagnostics management to meet with Craig-Hallum »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

SYF

Synchrony

$36.71

0.145 (0.40%)

07:38
11/15/19
11/15
07:38
11/15/19
07:38
Hot Stocks
Synchrony reports October net charge-off rate 3.54% vs. 3.84% last month »

Reports October 30-plus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$128.68

0.19 (0.15%)

07:38
11/15/19
11/15
07:38
11/15/19
07:38
Hot Stocks
JPMorgan reports October net credit loss 1.61% vs. 2.32% last month »

Reports October 30-plus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 14

    Jan

PRPL

Purple Innovation

$7.50

0.465 (6.61%)

07:38
11/15/19
11/15
07:38
11/15/19
07:38
Syndicate
Purple Innovation 10M share Secondary priced at $7.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

COF

Capital One

$96.64

0.31 (0.32%)

07:37
11/15/19
11/15
07:37
11/15/19
07:37
Hot Stocks
Capital One reports October net charge-offs 3.95% vs. 4.25% last year »

Reports 30-plus day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$1.10

0.01 (0.92%)

07:36
11/15/19
11/15
07:36
11/15/19
07:36
Hot Stocks
J.C. Penney expects liquidity to be at least $1.5B for remainder of the year »

The Company ended the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

CELG

Celgene

$110.03

-0.42 (-0.38%)

07:35
11/15/19
11/15
07:35
11/15/19
07:35
Hot Stocks
Celgene receives positive CHMP opinion for REVLIMID »

Celgene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 07

    Dec

  • 25

    Mar

  • 04

    Apr

JCP

J.C. Penney

$1.10

0.01 (0.92%)

07:35
11/15/19
11/15
07:35
11/15/19
07:35
Hot Stocks
J.C. Penney CEO says 'made significant progress' on efforts to return to growth »

"The past quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.